Injectable Drug Delivery Technology Market (By Formulation - Liposomes, Microspheres, Nanoparticles, Market By Device Type - Needle Free Injectors, Reusable Needles, Pre-Filled Syringes, Auto Injectors, Disposable Syringes, Pen Needle, Market By Mode Of Delivery - Intravenous, Intraperitoneal, Intramuscular, Subcutaneous, Market By Application- Oncology, Orphan Diseases, Auto-Immune Disease)- Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

Injection devices deliver the latest generation of drugs directly to the blood stream or to the specific tissues. During last few years there is a significant increase in the demand for the various injectable products as they offer a wide array of benefits such as safety, efficacy, and improve the stability. During last few years, there is a significant development in the injectable drug delivery technology.

Market Dynamics

The global injectable drug delivery technology market is majorly driven by rising prevalence of various chronic disease like cancer, diabetes, immunological disease and others. Increasing demand for the better and convenient route of administration for the medication and increasing government support will fueled the growth of the market. According to the World Health Organization (WHO), in 2014, approximately 422 million people across the globe were suffering from diabetes. Moreover, rising per capita income, rising awareness among the people, and increased the demand for the better treatment have boosted the growth of the market during the forecast period 2018—2026. On the other hand, risk of infection associated to the injection may slow the growth of the market.

Market Classification and Overview

The global injectable drug delivery technology market is segment into stroke type, device type, end-user, and region.

On the basis of formulation, the market is segmented nanoparticles, liposomes, microspheres, and others.

Based on the device type, the market is classified into needle free injectors, reusable needles, pre-filled syringes, auto injectors, pen needle, disposable syringes, and others.

On the basis of mode of delivery, the market is segmented into intraperitoneal, intravenous, intramuscular, subcutaneous, and others.

On the basis of application, the market is segmented into oncology, orphan diseases, auto-immune disease, and others.

Regional Overview

Geographically, the global injectable drug delivery technology market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to hold the major share in the global injectable drug delivery technology market owing increasing prevalence of various types of the medications, rising healthcare spending and increasing prevalence of the various chronic diseases in this region. Additionally, huge government support and presence of well developed economies has fuelled the growth of the market.

Europe accounts for the second leading position in the market followed by Asia Pacific. The major driving factors for the growth of the Europe market are increasing government support, presence of huge patient pool and high healthcare spending. Asia Pacific is the fastest growing region for the injectable drug delivery technology market during the forecast period 2016—2026 owing to presence of rapidly developing economies, increasing spending on research and development and increasing government support. On the other hand, LAMEA is expected to witness the steady growth in near future. The Middle East is expected to hold the major share for the market owing to the well developed healthcare sector and high spending on research and development.

Report Coverage

Market

Injectable Drug Delivery Technology Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Stroke Type, Device Type, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

The injectable drug delivery technology market comprises of some of the major players such as Alkermes Inc., Bend Research, Polymer Factory, Genentech Inc., MicroCHIPS, Inc., Presage Bioscience, QLT Inc., BIND Biosciences, Inc., Endocyte, Pearl Therapeutics Inc., and UCB Group.

Market Segmentation

Market By Formulation

  • Nanoparticles
  • Liposomes
  • Microspheres
  • Others

Market By Device Type

  • Needle Free Injectors
  • Reusable Needles
  • Pre-Filled Syringes
  • Auto Injectors
  • Pen Needle
  • Disposable Syringes
  • Others

Market By Mode Of Delivery

  • Intraperitoneal
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others

Market By  Application

  • Oncology
  • Orphan Diseases
  • Auto-Immune Disease
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary